Effect of 8 weeks of overfeeding on ectopic fat deposition and insulin sensitivity: Testing the "adipose tissue expandability" hypothesis

Diabetes Care

Volumn 37, Issue 10, 2014, Pages 2789-2797

  Johannsen, Darcy L ^a   Tchoukalova, Yourka ^a   Tam, Charmaine S ^a,b   Covington, Jeffrey D ^a   Xie, Wenting ^a   Schwarz, Jean Marc ^c   Bajpeyi, Sudip ^a,d   Ravussin, Eric ^a  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^b UNIVERSITY OF SYDNEY   (Australia)

^c Touro University California   (United States)

^d UNIVERSITY OF TEXAS AT EL PASO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; LIPID;

ABDOMINAL SUBCUTANEOUS FAT; ADIPOCYTE; ADIPOSE TISSUE; ADIPOSE TISSUE EXPANDABILITY; ADULT; ARTICLE; BODY MASS; CELL SIZE; CLAMP; CROSS-SECTIONAL STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID LIVER LEVEL; LIPID STORAGE; MALE; MUSCLE TISSUE; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERNUTRITION; PROTON NUCLEAR MAGNETIC RESONANCE; SKELETAL MUSCLE; TWO STEP HYPERINSULINEMIC EUGLYCEMIC CLAMP; UPREGULATION; WEIGHT GAIN; ABDOMINAL FAT; CLINICAL TRIAL; GLUCOSE CLAMP TECHNIQUE; LIVER; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; ORGAN SIZE; PATHOLOGY; PHYSIOLOGY; YOUNG ADULT;

ABDOMINAL FAT; ADIPOCYTES; ADIPOSE TISSUE; ADIPOSITY; ADULT; DIABETES MELLITUS, TYPE 2; GLUCOSE CLAMP TECHNIQUE; HUMANS; INSULIN; INSULIN RESISTANCE; LIVER; MALE; MUSCLE, SKELETAL; ORGAN SIZE; OVERNUTRITION; WEIGHT GAIN; YOUNG ADULT;

EID: 84908192495     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc14-0761     Document Type: Article

References (39)

1. Flegal KM, Carroll MD, Kit BK, Ogden CL. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA 2012;307:491-497.
2. Chen L, Magliano DJ, Zimmet PZ. The worldwide epidemiology of type 2 diabetes mellitusd present and future perspectives. Nat Rev Endocrinol 2012;8:228-236.
3. Unger RH, Scherer PE. Gluttony, sloth and the metabolic syndrome: a roadmap to lipotoxicity. Trends Endocrinol Metab 2010; 21:345-352.
4. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005;365:1415-1428.
5. Virtue S, Vidal-Puig A. Adipose tissue expandability, lipotoxicity and the Metabolic Syndromedan allostatic perspective. Biochim Biophys Acta 2010;1801:338-349.
6. Samuel VT, Shulman GI. Mechanisms for insulin resistance: common threads and missing links. Cell 2012;148:852-871.
7. Skurk T, Alberti-Huber C, Herder C, Hauner H. Relationship between adipocyte size and adipokine expression and secretion. J Clin Endocrinol Metab 2007;92:1023-1033.
8. Lê KA, Mahurkar S, Alderete TL, et al. Subcutaneous adipose tissue macrophage infiltration is associated with hepatic and visceral fat deposition, hyperinsulinemia, and stimulation of NF-kB stress pathway. Diabetes 2011;60: 2802-2809.
9. Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H, Flier JS. TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 2006;116:3015-3025.
10. Klöting N, Fasshauer M, Dietrich A, et al. Insulin-sensitive obesity. Am J Physiol Endocrinol Metab 2010;299:E506-E515.
11. Karelis AD, Faraj M, Bastard JP, et al. The metabolically healthy but obese individual presents a favorable inflammation profile. J Clin Endocrinol Metab 2005;90:4145-4150.
12. O'Connell J, Lynch L, Hogan A, Cawood TJ, O'Shea D. Preadipocyte factor-1 is associated with metabolic profile in severe obesity. J Clin Endocrinol Metab 2011;96:E680-E684.
13. Miyazaki Y, Mahankali A, Matsuda M, et al. Improved glycemic control and enhanced insulin sensitivity in type 2 diabetic subjects treated with pioglitazone. Diabetes Care 2001;24:710- 719.
14. Redman LM, Heilbronn LK, Martin CK, et al.; Pennington CALERIE Team. Metabolic and behavioral compensations in response to caloric restriction: implications for the maintenance of weight loss. PLoS ONE 2009; 4:e4377.
15. Heilbronn LK, de Jonge L, Frisard MI, et al.; Pennington CALERIE Team. Effect of 6-month calorie restriction on biomarkers of longevity, metabolic adaptation, and oxidative stress in overweight individuals: a randomized controlled trial. JAMA 2006;295:1539-1548.
16. Bray GA, Smith SR, de Jonge L, et al. Effect of dietary protein content on weight gain, energy expenditure, and body composition during overeating: a randomized controlled trial. JAMA 2012;307:47-55.
17. Snyder WSCM, Nasset ES, Karhausen LR, Howells GP, Tipton IH. Report of the Task Group on Reference Man. International Commission on Radiological Protection publication no. 23. Oxford, United Kingdom, Elsevier, 1975.
18. Larson-Meyer DE, Newcomer BR, Hunter GR. Influence of endurance running and recovery diet on intra myocellular lipid content in women: a 1H NMR study. Am J Physiol Endocrinol Metab 2002;282:E95-E106.
19. Naressi A, Couturier C, Devos JM, et al. Java-based graphical user interface for the MRUI quantitation package. MAGMA 2001;12: 141-152.
20. Rico-Sanz J, Thomas EL, Jenkinson G, Mierisová S, Iles R, Bell JD. Diversity in levels of intracellular total creatine and triglycerides in human skeletal muscles observed by (1)HMRS. J Appl Physiol (1985) 1999;87:2068-2072.
21. Vanhamme L, van den Boogaart A, VanHuffel S. Improved method for accurate and efficient quantification of MRS data with use of prior knowledge. J Magn Reson 1997;129:35-43.
22. Perseghin G, Scifo P, De Cobelli F, et al. Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans: a 1H-13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic parents. Diabetes 1999;48:1600-1606.
23. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979;237:E214-E223.
24. Lillioja S, Bogardus C. Obesity and insulin resistance: lessons learned from the Pima Indians. Diabetes Metab Rev 1988;4:517-540.
25. Bergstrom J. Percutaneous needle biopsy of skeletal muscle in physiological and clinical research. Scand J Clin Lab Invest 1975;35:609-616.
26. Kissebah AH, VydelingumN, Murray R, et al. Relation of body fat distribution to metabolic complications of obesity. J Clin Endocrinol Metab 1982;54:254-260.
27. Hirsch J, Gallian E. Methods for the determination of adipose cell size in man and animals. J Lipid Res 1968;9:110-119.
28. PasaricaM, Xie H, Hymel D, et al. Lower total adipocyte number but no evidence for small adipocyte depletion in patients with type 2 diabetes. Diabetes Care 2009;32:900-902.
29. Tam CS, Covington JD, Bajpeyi S, et al. Weight gain reveals dramatic increases in skeletal muscle extracellular matrix remodeling. J Clin Endocrinol Metab 2014;99:1749-1757.
30. Weyer C, Foley JE, Bogardus C, Tataranni PA, Pratley RE. Enlarged subcutaneous abdominal adipocyte size, but not obesity itself, predicts type II diabetes independent of insulin resistance. Diabetologia 2000;43:1498-1506.
31. Yang J, Eliasson B, Smith U, Cushman SW, Sherman AS. The size of large adipose cells is a predictor of insulin resistance in first-degree relatives of type 2 diabetic patients. Obesity (Silver Spring) 2012;20:932-938.
32. Kursawe R, EszlingerM, Narayan D, et al. Cellularity and adipogenic profile of the abdominal subcutaneous adipose tissue from obese adolescents: association with insulin resistance and hepatic steatosis. Diabetes 2010;59:2288-2296.
33. Ravussin E, Swinburn BA. Metabolic predictors of obesity: cross-sectional versus longitudinal data. Int J Obes Relat Metab Disord 1993;17(Suppl. 3):S28-S31; discussion S41-S42.
34. Boden G, Shulman GI. Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction. Eur J Clin Invest 2002;32 (Suppl. 3):14-23.
35. Kraegen EW, Cooney GJ, Turner N. Muscle insulin resistance: a case of fat overconsumption, not mitochondrial dysfunction. Proc Natl Acad Sci U S A 2008;105:7627-7628.
36. Yu C, Chen Y, Cline GW, et al. Mechanismby which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J Biol Chem 2002;277:50230-50236.
37. Varma V, Yao-Borengasser A, Rasouli N, et al. Muscle inflammatory response and insulin resistance: synergistic interaction between macrophages and fatty acids leads to impaired insulin action. Am J Physiol Endocrinol Metab 2009;296:E1300-E1310.
38. Marques BG, Hausman DB, Martin RJ. Association of fat cell size and paracrine growth factors in development of hyperplastic obesity. Am J Physiol 1998;275:R1898-R1908.
39. Sun K, Scherer PE. Adipose Tissue Dysfunction: A Multistep Process. Berlin, Germany, Springer-Verlag Berlin Heidelberg, 2010.